Eu(III), Tb(III), and Gd(III) Complexes With Dual Ligand Architecture: Synthesis, Characterization, Photoluminescence, Cytotoxic, and Molecular Docking Studies.
- 1 July 2026
- journal article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (7) , e71502
Abstract
By using the naphthalene group-containing β-diketone ligand and 5-nitro-1,10-phenanthroline, three novel heteroleptic eight-coordinate complexes of Eu(III), Tb(III), and Gd(III) have been synthesized. Methods such as elemental analysis, MALDI TOF-MS, UV-Vis, and FT-IR were used to determine the structural characterization of these compounds. The photoluminescent characteristics of the synthesized complexes of Eu(III), Tb(III), and Gd(III) were further investigated. The ligand (L1) and co-ligand 5-nitro-1,10-phenanthroline (L2) and its three lanthanide complexes [Eu(L1)3(L2)]·3H2O, [Tb(L1)3(L2)], and [Gd(L1)3(L2)] were tested in human breast (MCF-7), colon (DLD-1), and lung (A549) cancer cell lines for 72 h. Furthermore, these compounds were screened in a human embryonic kidney cell line (HEK-293T) for cytotoxicity. The results demonstrated that these compounds have antiproliferative activity in three cancer cell lines with low IC50 values. The probable mode of action for the cytotoxic effect was explored through molecular modeling. Previous studies reported epidermal growth factor receptor (EGFR)-inhibiting potential for compounds with similar scaffolds. The docking study demonstrated that the three chelates would have the potential to bind to the EGFR structure. The molecular dynamics (MD) simulation study consolidated this finding as the complex structures were found to be stable with some differences. MMPBSA (molecular mechanics with Poisson-Boltzmann and surface area solvation) energy calculation results also showed high binding affinities for the chelates.Keywords
This publication has 56 references indexed in Scilit:
- Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(iii) and Ir(iii) complexesDalton Transactions, 2013
- Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agentsBioorganic & Medicinal Chemistry, 2013
- Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom TypingJournal of Chemical Information and Modeling, 2012
- Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategiesChemical Society Reviews, 2012
- Crystal structures, antioxidation and DNA binding properties of Eu(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carboxyaldehyde and three aroylhydrazinesJournal of Inorganic Biochemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Structural and Photoluminescence Studies of a Europium(III) Tetrakis(β-diketonate) Complex with Tetrabutylammonium, Imidazolium, Pyridinium and Silica-Supported Imidazolium CounterionsInorganic Chemistry, 2009
- Formation and Stability of Mononuclear and Dinuclear Eu(III) Complexes and Their Catalytic Reactivity Toward Cleavage of an RNA AnalogInorganic Chemistry, 2007
- Metal-based antitumour drugs in the post genomic eraDalton Transactions, 2006
- Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline InhibitorJournal of Biological Chemistry, 2002